课题基金 / 基金详情

Context, Heterogeneity and Large-Scale Interventions: Scaling up Antiretroviral HIV Treatment as Prevention in Canada, France and Brazil

Context, Heterogeneity and Large-Scale Interventions: Scaling up Antiretroviral HIV Treatment as Prevention in Canada, France and Brazil
背景、异质性和大规模干预措施:在加拿大、法国和巴西扩大抗逆转录病毒艾滋病毒治疗作为预防
批准号:
311377
负责人:
Knight Rodney E
金额:
$0.18万
依托单位国家:
加拿大
项目类别:
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-05-01 至 2014-08-01

项目摘要

项目成果

Knight Rodney E的其他基金

相似基金

相关文献

中文摘要
翻译
越来越多的证据表明,抗逆转录病毒“治疗即预防”(TasP)有望通过防止血清阳性个体的疾病进展来减少艾滋病毒的发病率(从而降低疾病传播的可能性
英文摘要
There is growing evidence demonstrating the promise of antiretroviral 'Treatment as Prevention' (TasP) in reducing HIV incidence by preventing disease progression among seropositive individuals (and thus decreasing the likelihood of onward disease transmi
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Establishing an international research and policy collaborative to improve health outcomes for sexual minority men who use poppers (alkyl nitrites)
  • 批准号:
    460787
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $1.34万
  • 财政年份:
    2022
  • 负责人:
    Knight Rodney E
  • 依托单位:
A FOCUS on youth mental health and substance use-related outcomes, inequities and trajectories during COVID-19 and beyond: A mixed-methods study in Canada and France
  • 批准号:
    473349
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Knight Rodney E
  • 依托单位:
COVID-19 Variant Supplement - Assessing the impact of the COVID-19 pandemic on social and health outcomes among young people: A mixed-method comparative analysis in Canada and France
  • 批准号:
    443136
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Knight Rodney E
  • 依托单位:
Side by Side: Identifying strategies to address the health and social needs of youth who use stimulants
国内基金
海外基金
人类免疫缺陷病毒(HIV)总核酸检测试剂盒
HIV相关肺癌免疫微环境中关键免疫细胞亚群的功能特征与调控机制研究
基于深度测序与SNV 芯片的HIV重复感染与毒株重组机制研究
  • 批准号:
    2026JJ81281
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    徐艳
  • 依托单位:
PGT123中和抗体修饰的工程化载肽囊泡疫苗通过诱导CD4+ T细胞极化在抗HIV感染中的应用和机制研究